Shareholder Analysis

Significant Shareholdings

As at 29 April 2022, the Company’s issued share capital consists of 216,071,141 ordinary shares with a nominal value of 5p each (“Ordinary Shares”), each share having equal voting rights.

As at 29 April 2022 the Company’s major shareholders are:

Table: “Significant shareholdings”

 

 

Shareholders Percentage of shares held
Octopus Investments Limited 12.54%
Canaccord Genuity Group Inc 6.86%
Charles Stanley Group 5.22%
Investec Group 4.92%
Invesco 4.29%
AXA SA 3.88%
Groupama 3.28%
Rathbone Plc 3.20%

 

In accordance with the AIM Rules (Rule 26), insofar as the Company is aware as at 29 April 2022, the percentage of the Company’s issued share capital that is not in public hands is 14.01%. This percentage consists of the holdings of the directors’ beneficial holdings, the holdings of the AMS Trustee Company in respect of the Company’s Deferred Share Bonus Scheme, and the Company’s substantial shareholders. The Company’s free float is 85.99%.

Any corporate shareholders who wish to contact AMS, or provide information on their shareholding, can send an email to companysecretary@admedsol.com.